Schizophrenia.com

Review Examines Metabolic, Cardiovascular Side Effects of Second-Generation antipsychotics

everhopeful April 5, 2021, 4:03pm 1

1 Like

Topic		Replies	Views	Activity
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects News	0	216	March 9, 2021
Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia News	0	326	September 19, 2019
Not All Antipsychotics Affect Metabolic Health Equally in Schizophrenia News	0	308	February 7, 2023
Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics News	0	230	July 23, 2021
Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study News	0	425	February 7, 2015